10-Year retrospective review of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) toxic doses in children < 6 years old

被引：0
|
作者：
Pham, Trang [1 ]
Ostrikova, Kim Vo [1 ]
Winter, Mark L. [1 ]
机构：
[1] Southeast Texas Poison Control Ctr, Galveston, TX USA
来源：
CLINICAL TOXICOLOGY | 2023年 / 61卷
关键词：
ACE; ARB;
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
343
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [21] Angiotensin II-receptor blockers: will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?
    Kaplan, NM
    JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (Suppl 1) : S87 - S90
  • [22] The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes
    Padwal, Raj
    Lin, Mu
    Eurich, Dean T.
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (03): : 200 - 206
  • [23] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on peritoneal transport Reply
    Nessim, Sharon J.
    Perl, Jeffrey
    Bargman, Joanne M.
    KIDNEY INTERNATIONAL, 2011, 79 (01) : 137 - 137
  • [24] Effects of some angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on experimental inflammations
    Magyar, Ioan
    Cret, Mihai
    Cuparencu, Barbu
    FASEB JOURNAL, 2013, 27
  • [25] Angiotensin II-receptor blockers: will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?
    NM Kaplan
    Journal of Human Hypertension, 2000, 14 : S87 - S90
  • [26] Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children
    Vaz de Castro, Pedro Alves Soares
    Bitencourt, Leticia
    Pereira, Bruno Wilnes Simas
    Lima, Ananda Queiroz Rocha
    Hermida, Henrique Santos
    Moreira Neto, Carlos Roberto
    Mestriner, Mariana Dinamarco
    Simoes e Silva, Ana Cristina
    PEDIATRIC NEPHROLOGY, 2022, 37 (03) : 499 - 508
  • [27] Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children
    Pedro Alves Soares Vaz de Castro
    Letícia Bitencourt
    Bruno Wilnes Simas Pereira
    Ananda Queiroz Rocha Lima
    Henrique Santos Hermida
    Carlos Roberto Moreira Neto
    Mariana Dinamarco Mestriner
    Ana Cristina Simões e Silva
    Pediatric Nephrology, 2022, 37 : 499 - 508
  • [28] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
    Mc Menamin, Una C.
    Murray, Liam J.
    Cantwell, Marie M.
    Hughes, Carmel M.
    CANCER CAUSES & CONTROL, 2012, 23 (02) : 221 - 230
  • [29] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
    Úna C. Mc Menamin
    Liam J. Murray
    Marie M. Cantwell
    Carmel M. Hughes
    Cancer Causes & Control, 2012, 23 : 221 - 230
  • [30] Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
    ElAbd, Rawan
    AlTarrah, Dana
    AlYouha, Sarah
    Bastaki, Hamad
    Almazeedi, Sulaiman
    Al-Haddad, Mohannad
    Jamal, Mohammad
    AlSabah, Salman
    FRONTIERS IN MEDICINE, 2021, 8
12345